These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 18645097)
61. Muscle Insertion and Strength of the Muscle Contraction as Guidelines to Enhance Duration of the Botulinum Toxin Effect in the Upper Face. Abramo AC Aesthetic Plast Surg; 2018 Oct; 42(5):1379-1387. PubMed ID: 29987485 [TBL] [Abstract][Full Text] [Related]
62. A new technique applying botulinum toxin in narrow and wide foreheads. Ozsoy Z; Genc B; Gözü A Aesthetic Plast Surg; 2005; 29(5):368-72. PubMed ID: 16151661 [TBL] [Abstract][Full Text] [Related]
63. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead? Kim YJ; Lim OK; Choi WJ Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751 [TBL] [Abstract][Full Text] [Related]
64. Botulinum toxin type A reconstituted in lidocaine with epinephrine for facial rejuvenation: results of a participant satisfaction survey. Kim A; Jung J; Pak A Cutis; 2013 Jul; Suppl():13-8. PubMed ID: 24308152 [TBL] [Abstract][Full Text] [Related]
65. Frozen versus fresh reconstituted botox for laryngeal dystonia. Thomas JP; Siupsinskiene N Otolaryngol Head Neck Surg; 2006 Aug; 135(2):204-8. PubMed ID: 16890068 [TBL] [Abstract][Full Text] [Related]
66. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. Kongsengdao S; Kritalukkul S J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887 [TBL] [Abstract][Full Text] [Related]
67. The use of botulinum toxin type A in cosmetic facial procedures. Jaspers GW; Pijpe J; Jansma J Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695 [TBL] [Abstract][Full Text] [Related]
68. Pilot trial of onabotulinumtoxina (Botox) in moderate to severe restless legs syndrome. Agarwal P; Sia C; Vaish N; Roy-Faderman I Int J Neurosci; 2011 Nov; 121(11):622-5. PubMed ID: 21740308 [TBL] [Abstract][Full Text] [Related]
69. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles. Michaels BM; Csank GA; Ryb GE; Eko FN; Rubin A Aesthet Surg J; 2012 Jan; 32(1):96-102. PubMed ID: 22231417 [TBL] [Abstract][Full Text] [Related]
70. Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection. Barrow EM; Rosen CA; Hapner ER; Smith S; Hatcher JL; Simpson B; Johns MM Laryngoscope; 2015 May; 125(5):1149-54. PubMed ID: 25476036 [TBL] [Abstract][Full Text] [Related]
71. Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing. West TB; Alster TS Dermatol Surg; 1999 Apr; 25(4):259-61. PubMed ID: 10417577 [TBL] [Abstract][Full Text] [Related]
72. Long-term effects of botulinum toxin type A (Botox) on facial lines: a comparison in identical twins. Binder WJ Arch Facial Plast Surg; 2006; 8(6):426-31. PubMed ID: 17116793 [TBL] [Abstract][Full Text] [Related]
73. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions. Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469 [TBL] [Abstract][Full Text] [Related]
74. RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study. Lee DH; Kang SM; Feneran A; Youn CS; Kim JK; Cho S; Won CH; Chang SE; Lee MW; Choi JH; Moon KC J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e1-7. PubMed ID: 23030660 [TBL] [Abstract][Full Text] [Related]
75. A prospective evaluation of the efficacy of topical adhesive pads for the reduction of facial rhytids. Ryan WR; Most SP Arch Facial Plast Surg; 2009; 11(4):252-6. PubMed ID: 19620531 [TBL] [Abstract][Full Text] [Related]
76. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA. Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460 [TBL] [Abstract][Full Text] [Related]
77. Botox and the gummy smile. Gracco A; Tracey S Prog Orthod; 2010; 11(1):76-82. PubMed ID: 20529632 [TBL] [Abstract][Full Text] [Related]
78. Foam during reconstitution does not affect the potency of botulinum toxin type A. Trindade De Almeida AR; Kadunc BV; Di Chiacchio N; Neto DR Dermatol Surg; 2003 May; 29(5):530-1; discussion 532. PubMed ID: 12752523 [TBL] [Abstract][Full Text] [Related]
79. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation. Stone HF; Zhu Z; Thach TQ; Ruegg CL Toxicon; 2011 Aug; 58(2):159-67. PubMed ID: 21658400 [TBL] [Abstract][Full Text] [Related]